SenesTech (NASDAQ:SNES – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($1.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28, Zacks reports. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%.
SenesTech Price Performance
NASDAQ:SNES traded down $0.08 during trading hours on Wednesday, reaching $2.30. 300,691 shares of the company were exchanged, compared to its average volume of 76,123. SenesTech has a 52-week low of $1.90 and a 52-week high of $9.80. The stock has a 50 day simple moving average of $3.08 and a 200 day simple moving average of $2.86. The company has a debt-to-equity ratio of 0.05, a quick ratio of 4.92 and a current ratio of 6.32.
Analyst Upgrades and Downgrades
Several research firms have weighed in on SNES. HC Wainwright upped their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th. StockNews.com started coverage on shares of SenesTech in a research note on Sunday. They issued a “sell” rating on the stock.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- Basic Materials Stocks Investing
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Investing In Automotive Stocks
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.